Oncolytic viral therapy as a novel potential solution for treatment of pancreatic cancer

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Pancreatic cancer (PC) has dismal survival rates despite advances in conventional therapies.
• Current treatments like chemotherapy and radiation offer limited impact on 5-year survival.
• Emerging research into PC's genetic and molecular landscape reveals new therapeutic targets.

Purpose of the Study:

• To review the potential of oncolytic viruses as a targeted therapy for pancreatic cancer.
• To explore the mechanisms and applications of oncolytic viral therapy in PC treatment.
• To assess oncolytic viral therapy as a future alternative treatment for pancreatic cancer.

Main Methods:

• This study is a narrative review of existing literature on oncolytic viruses and pancreatic cancer.
• Literature search focused on genetic and molecular underpinnings of PC and viral therapy applications.
• Analysis of evidence supporting oncolytic viral therapy's efficacy and viability.

Main Results:

• Oncolytic viral therapy has emerged as a promising targeted approach for pancreatic cancer.
• The genetic and molecular understanding of PC supports the development of novel targeted agents.
• Available evidence suggests oncolytic viral therapy is a viable treatment option.

Conclusions:

• Oncolytic viral therapy presents a potential breakthrough in pancreatic cancer treatment.
• Further research and clinical application of oncolytic viruses could significantly impact PC outcomes.
• This therapy offers a future alternative for managing this challenging malignancy.